Similar Articles
891 Image quality and diagnostic performance of free-breathing diffusion-weighted imaging for hepatocellular carcinoma
892 Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B
893 Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
894 Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma
895 Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
896 Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort
897 Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
898 CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma
899 Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
900 Case of hepatocellular carcinoma in a patient with hereditary tyrosinemia in the post-newborn screening era
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA